News & Media

TruTag Technologies Selected as Finalist for the CPhI Pharma Awards

TruTag’s On-Dose Authentication solution for solid-dose drugs recognized in the “Excellence in Pharma:  Excipients” category

EMERYVILLE, CALIFORNIA ─ October 23, 2017 — TruTag Technologies, a leading security and technology solution provider has been named to the official shortlist for the 2017 CPhI Pharma Awards as a finalist in the “Excellence in Pharma: Excipients” category. The CPhI Pharma Awards were established in 2004 and is among the most prestigious recognition within the Pharmaceutical industry.

The 2017 edition of the CPhI Pharma Awards accepted entries in 19 categories covering the entire spectrum of pharma including API development, formulation, excipients, bioprocessing, drug delivery devices, packaging, OTC, manufacturing technology and equipment. TruTag Technologies stands as one of five shortlisted organizations in the Excipients category among Colorcon, Ideal Cures Pvt. Ltd., Merck and The Dow Chemical Company.

TruTag Technologies improves the safety, traceability, and authenticity of pharmaceuticals with its on-dose authentication technology solution. TruTag’s silicon dioxide particle-based microtags, known as “TruTags®”, uniquely enable customers to authenticate, identify and trace solid oral dosage form (SODF) drugs along the entire length of a supply chain by generating an optical signature. TruTags are etched in batches to create unique combinations of nano-pores that reflect light at discrete, selected wavelengths that are authenticated by the company’s portable readers; therefore, each TruTag possesses an optical signature that is unique, identifiable, and extremely secure.

“We would like to thank the CPhI Pharma Awards for their recognition of the TruTag on-dose authentication technology solution,” said Michael Bartholomeusz, Chief Executive Officer of TruTag Technologies. “This recognition speaks to the depth of experience, industry knowledge, and technical expertise of the TruTag team in bringing forth one of the most secure and reliable authentication solutions to the pharma industry.”

Taking place on October 24, the first evening of CPhI Worldwide, the world’s largest pharma trade show attracting attendees from over 150 countries, the CPhI Awards Gala will take place at the Intercontinental Hotel in Frankfurt, Germany to celebrate the winners for their excellence in pharma.

About TruTag Technologies, Inc.

TruTag Technologies, Inc. is a leading security and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for a variety of applications and security solutions, including product identity for food, medicine, secure labels and documents. The company’s highly-specialized nano-porous silica particles extend to precision drug delivery systems for the biopharmaceutical industry. TruTag’s nano-fabrication technology platform is complemented by its advanced hyperspectral imaging solutions, which can be applied to a broad array of market applications from medical diagnostics to machine vision.

TruTag Technologies has been recognized by the SPIE Prism Awards, Frost & Sullivan, the Edison Awards, Fast Company, R&D 100, and was selected a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world. Learn more at

©2017 All rights reserved. TRUTAG and TRUTAGS are registered trademarks of TruTag Technologies, Inc.

Media Contacts:

TruTag Technologies
Paula Page
P: 650.279.3881